Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia.
Ernst T, Hoffmann J, Erben P, Hehlmann R, Hochhaus A, Müller MC
Purpose
Conclusion
Studies (1)
Purpose
This study compared PAXgene system stabilized bone marrow and blood specimens in regard to RNA yield, reference and target gene expression, and the prevalence of a gene mutation. Blood was collected directly into PAXgene tubes and frozen at -20°C after 2 h. Bone marrow was collected into EDTA or citrate syringes and tranferred to PAXgene tubes.
Summary of Findings
Bone marrow specimens subjected to the PAXgene system for RNA stabilization generated greater RNA yields of comparable quality to those of corresponding blood specimens. Reference gene expression (total ABL, GUS) were significantly higher in bone marrow compared to blood specimens, while target BCR-ABL ratios did not differ among biospecimen locations. While BCR-ABL kinase domain mutation analysis generated concordant results for 93% of patients, the proportion of the mutation was significantly lower in bone marrow compared to blood (50 versus 70%).
Biospecimens
FluidBone MarrowFluidBloodPreservation Types
PAXgeneDiagnoses
NeoplasticLeukemiaPlatforms
RNASpectrophotometryRNAReal-time qRT-PCRDNAHPLCDNADNA sequencingPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location BloodBone marrow